name | Minoxidil |
classification | Peripheral vasodilator, Antihypertensive, Topical hair growth promoter |
pharmacokinetics | absorption | Topical application results in variable absorption, with systemic absorption possible. Systemic absorption is generally lower with topical formulations compared to oral administration. | distribution | Distributed throughout the body, with potential for accumulation in tissues. | metabolism | Primarily metabolized by the liver. Metabolism can vary depending on individual factors. | excretion | Eliminated primarily through urine, with some excretion in the bile. |
|
suggested dosage | topical hair growth | description | Commonly applied twice daily. Specific concentrations and application frequency may vary based on the product. Consult with a dermatologist for specific recommendations. | notes | Follow manufacturer instructions carefully. |
| oral antihypertensive | description | Dosage is highly individualized based on blood pressure response and patient tolerance. It is critical to follow the prescribing physician's instructions carefully. | notes | Should not be self-administered; only for severe hypertension under medical supervision. |
|
|
indications | topical hair growth | Treatment of androgenetic alopecia (male pattern baldness). | oral antihypertensive | Treatment of severe, resistant hypertension. |
|
safety in pregnancy | description | Limited data on use during pregnancy. Potential risks to the fetus are unknown. Should not be used during pregnancy unless clinically warranted and benefits outweigh risks. Consult with a healthcare professional. | cautions | Minoxidil should be used only when absolutely necessary during pregnancy. |
|
safety in breastfeeding | description | Limited data on use during breastfeeding. Potential for excretion into breast milk is unknown. Avoid use in lactating mothers. | cautions | Safety concerns exist, and use during breastfeeding is not recommended. |
|
side effects | 1 | Topical application: Skin irritation, redness, itching, dryness. Hair growth may be patchy. | 2 | Systemic application (oral): Fluid retention (edema), dizziness, palpitations, headache, cardiac complications, and severe hypotension. | 3 | Other: Possible changes in blood pressure and heart rate. |
|
alternatives | |
contraindications | 1 | Hypersensitivity to minoxidil or related compounds. | 2 | Severe heart conditions (e.g., uncontrolled heart failure) | 3 | Renal insufficiency | 4 | Pregnancy (unless clinically necessary). | 5 | Breastfeeding. |
|
interactions | 1 | Concurrent use with other antihypertensive medications can result in additive hypotension. | 2 | Concurrent use with certain medications may alter minoxidil's metabolism | 3 | Consult a physician before using other medications concurrently. |
|
warnings and precautions | 1 | Close monitoring of blood pressure and fluid balance is crucial, especially when used orally. | 2 | Topical formulations may have variability in efficacy. Consult a dermatologist for specific application details. | 3 | Do not use minoxidil in large quantities or frequently in the treatment of hair loss. Follow the instructions carefully. | 4 | Patients with a history of cardiovascular disease, kidney disease or other medical problems should consult with a physician before taking minoxidil. |
|
additional informations | important note | This information is for general knowledge only and should not be considered medical advice. Always consult a qualified healthcare professional for personalized medical advice, diagnosis, and treatment. | for age weight | The dosage and use of minoxidil for a 25-year-old male weighing 70kg will differ based on the indication (hair growth or hypertension). Consultation with a physician is required. | monitoring | Regular monitoring for blood pressure, fluid retention and other potential adverse effects is essential. |
|